Pancreatic Cancer Trial, Recruiting NCT05871164 Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT05871164
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who are being treated for a pancreatic tumour using a procedure called radiofrequency ablation, which uses heat delivered through a fine needle guided by ultrasound
  • People whose case has been reviewed and approved for this procedure by a team of specialists in a formal medical meeting
  • People who are able to understand the information provided about the study
  • People who are willing to attend follow-up visits as part of the study
  • People who have been informed about the study and have agreed to take part

Who may not be able to join:

  • People for whom radiofrequency treatment is medically unsuitable or not recommended (confirm with trial site for specific details)
  • Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 428636969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Registry
ClinicalTrials.gov
Start date
12 June 2023
Est. completion
1 May 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Carcinological efficacy of pancreatic radiofrequency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov